Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex

Background. Multiple sclerosis (MS) is an autoimmune inflammatory disease of central nervous system (CNS). MS affects quality of Life (QOL) due to physical disability and other associated problems. Disease-modifying agents like interferon beta (IFNB) have been widely utilized in this patient populat...

Full description

Saved in:
Bibliographic Details
Main Authors: Abolfazli, R., Hosseini, A., Gholami, Kh., Javadi, M. R., Torkamandi, H., Emami, S.
Format: Artigo
Language:Inglês
Published: International Scholarly Research Network 2012
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3423918/
https://ncbi.nlm.nih.gov/pubmed/22928117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2012/786526
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items